Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
This weight loss drug helped people shed more pounds than Wegovy, new trial results show
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Weight-loss drug Mounjaro will help 'so many' people, say users
It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold privately by clinics and pharmacies. BBC News spoke to people who are already paying to access Mounjaro,
Weight loss drug Mounjaro will be available via the NHS for some people living with obesity
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone who meets the criteria to actually receive it,
Everything we know about Mounjaro, the new NHS weight loss jab
Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the injections will be given out from March, the health service is too overstretched to roll it out immediately.
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it? - Fewer than 10% of patients in England who are eligible will initially be able to access it on the NHS.
Hosted on MSN
14h
How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study
Eli Lilly and Company LLY announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed ...
2d
In new trial, Zepbound bests Wegovy for weight loss
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
1d
Zepbound Leads to More Weight Loss Than Wegovy in Head-to-Head Clinical Trial
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
20h
on MSN
What is Mounjaro and how does it compare to other weight loss medications?
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
FiercePharma
14h
AbbVie’s Skyrizi retains DTC spending crown, as Novo’s Wegovy sees first entry
That’s according to the latest data from real-time ad trackers iSpot.TV. Their analysts found AbbVie’s immunology drug duo ...
The Root on MSN
2d
Stop Listening to These Tired 5 Ozempic, Wegovy Myths And Save Your Health
As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, Black people need ...
WebMD
2d
Wegovy vs. Zepbound: New Data Declares a Winner
People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.
Newsday
10d
Wegovy, Mounjaro: Suffolk County issues new guidelines for access to costly weight-loss drugs
The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...
2d
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
18h
Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup
Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Zepbound
Eli Lilly and Company
Feedback